Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Nikitas

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
JAMA Oncology|February 12, 2026
Redefining Salvage Therapy for Localized Radiorecurrent Prostate Cancer-In More Ways Than OneJohn Nikitas, Neha Vapiwala
The Lancet. Oncology|May 3, 2025
Limitations in the meta-analysis of prostate radiotherapy-associated toxicity - Authors' replyAmar U Kishan, Parsa Jamshidian, John Nikitas
JAMA Oncology|October 2, 2025
Concerns Regarding Follow-Up Duration and End Point Validity-ReplyAmar U Kishan, Michael L Steinberg, John Nikitas
Clinical Lung Cancer|November 28, 2018
Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung CancersJohn Nikitas, Todd DeWees, Sana Rehman, et al.
Clinical Genitourinary Cancer|February 4, 2023
Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) BrachytherapyJohn Nikitas, Minsong Cao, Nicholas G Nickols, et al.
Clinical and Translational Radiation Oncology|January 21, 2020
Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)John Nikitas, Michael Roach, Cliff Robinson, et al.
Practical Radiation Oncology|September 24, 2018
Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation TherapyTodd A DeWees, John Nikitas, Sana Rehman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2019
Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRTWilliam R Kennedy, Prashant Gabani, John Nikitas, et al.
Clinical and Translational Radiation Oncology|March 13, 2019
Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapyWilliam R Kennedy, Prashant Gabani, John Nikitas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2020
Impact of invasive nodal staging on regional and distant recurrence rates after SBRT for inoperable stage I NSCLCWilliam R Kennedy, Pamela P Samson, Prashant Gabani, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
JAMA Oncology|February 12, 2026
Redefining Salvage Therapy for Localized Radiorecurrent Prostate Cancer-In More Ways Than OneJohn Nikitas, Neha Vapiwala
The Lancet. Oncology|May 3, 2025
Limitations in the meta-analysis of prostate radiotherapy-associated toxicity - Authors' replyAmar U Kishan, Parsa Jamshidian, John Nikitas
JAMA Oncology|October 2, 2025
Concerns Regarding Follow-Up Duration and End Point Validity-ReplyAmar U Kishan, Michael L Steinberg, John Nikitas
Clinical Lung Cancer|November 28, 2018
Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung CancersJohn Nikitas, Todd DeWees, Sana Rehman, et al.
Clinical Genitourinary Cancer|February 4, 2023
Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) BrachytherapyJohn Nikitas, Minsong Cao, Nicholas G Nickols, et al.
Clinical and Translational Radiation Oncology|January 21, 2020
Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)John Nikitas, Michael Roach, Cliff Robinson, et al.
Practical Radiation Oncology|September 24, 2018
Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation TherapyTodd A DeWees, John Nikitas, Sana Rehman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2019
Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRTWilliam R Kennedy, Prashant Gabani, John Nikitas, et al.
Clinical and Translational Radiation Oncology|March 13, 2019
Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapyWilliam R Kennedy, Prashant Gabani, John Nikitas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2020
Impact of invasive nodal staging on regional and distant recurrence rates after SBRT for inoperable stage I NSCLCWilliam R Kennedy, Pamela P Samson, Prashant Gabani, et al.
Pageof 4